SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - FRA:SNW - FR0000120578 - Common Stock
84.94 EUR
+6.4 (+8.15%)
SNW gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 51 industry peers in the Pharmaceuticals industry. SNW has an excellent profitability rating, but there are some minor concerns on its financial health. SNW has a decent growth rate and is not valued too expensively. SNW also has an excellent dividend rating. These ratings could make SNW a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
SNW had positive earnings in the past year.
In the past year SNW had a positive cash flow from operations.
SNW had positive earnings in each of the past 5 years.
SNW had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SNW has a Return On Assets of 11.05%. This is in the better half of the industry: SNW outperforms 76.47% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, SNW is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
With a decent Return On Invested Capital value of 13.84%, SNW is doing good in the industry, outperforming 72.55% of the companies in the same industry.
SNW had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 15.11%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
With a decent Profit Margin value of 20.35%, SNW is doing good in the industry, outperforming 78.43% of the companies in the same industry.
SNW's Profit Margin has improved in the last couple of years.
SNW's Operating Margin of 23.59% is fine compared to the rest of the industry. SNW outperforms 60.78% of its industry peers.
SNW's Operating Margin has improved in the last couple of years.
SNW has a Gross Margin of 71.70%. This is comparable to the rest of the industry: SNW outperforms 58.82% of its industry peers.
SNW's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNW is creating value.
Compared to 1 year ago, SNW has about the same amount of shares outstanding.
SNW has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for SNW has been reduced compared to a year ago.
2.2 Solvency
SNW has a debt to FCF ratio of 2.21. This is a good value and a sign of high solvency as SNW would need 2.21 years to pay back of all of its debts.
SNW has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. SNW outperforms 84.31% of its industry peers.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
SNW has a better Debt to Equity ratio (0.21) than 72.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.63%
2.3 Liquidity
SNW has a Current Ratio of 1.27. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, SNW perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
SNW's Quick ratio of 0.94 is in line compared to the rest of the industry. SNW outperforms 50.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -2.20% in the last year.
SNW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.10% yearly.
The Revenue has been growing slightly by 6.45% in the past year.
Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
Based on estimates for the next years, SNW will show a small growth in Earnings Per Share. The EPS will grow by 6.41% on average per year.
Based on estimates for the next years, SNW will show a small growth in Revenue. The Revenue will grow by 4.04% on average per year.
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.41%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.25, which indicates a very decent valuation of SNW.
84.31% of the companies in the same industry are more expensive than SNW, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SNW to the average of the S&P500 Index (27.79), we can say SNW is valued rather cheaply.
SNW is valuated reasonably with a Price/Forward Earnings ratio of 9.79.
80.39% of the companies in the same industry are more expensive than SNW, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.21, SNW is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.25 | ||
| Fwd PE | 9.79 |
4.2 Price Multiples
SNW's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.57 | ||
| EV/EBITDA | 10.13 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.73
PEG (5Y)2.21
EPS Next 2Y6.3%
EPS Next 3Y6.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.93%, SNW is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.03, SNW pays a better dividend. On top of this SNW pays more dividend than 86.27% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SNW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.93% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
FRA:SNW (10/1/2025, 7:00:00 PM)
84.94
+6.4 (+8.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap207.16B
Analysts80
Price Target110.07 (29.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.93% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)0.32%
PT rev (3m)-5.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)0.21%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.25 | ||
| Fwd PE | 9.79 | ||
| P/S | 3.05 | ||
| P/FCF | 20.57 | ||
| P/OCF | 18.2 | ||
| P/B | 2.96 | ||
| P/tB | 22.29 | ||
| EV/EBITDA | 10.13 |
EPS(TTM)7.55
EY8.89%
EPS(NY)8.68
Fwd EY10.22%
FCF(TTM)4.13
FCFY4.86%
OCF(TTM)4.67
OCFY5.49%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.73
PEG (5Y)2.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.63%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y4.12%
EPS Next 2Y6.3%
EPS Next 3Y6.57%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year-0.29%
Revenue Next 2Y3.32%
Revenue Next 3Y4.42%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%